Cargando…

The seroprevalence of immunoglobulin A transglutaminase in type 1 diabetic patients of South Indian origin

CONTEXT: Celiac disease (CD) is a commonly encountered autoimmune condition in patients with type 1 diabetes (T1D). There is sparse data on the seroprevalence of immunoglobulin A (IgA) transglutaminase (tTG) in T1D patients of South Indian origin. AIMS: To detect the prevalence of IgA tTG in T1D pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pulikkal, Annie A., Kolly, Anish, Prasanna Kumar, K. M., Shivaprasad, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792026/
https://www.ncbi.nlm.nih.gov/pubmed/27042421
http://dx.doi.org/10.4103/2230-8210.176359
_version_ 1782421182027399168
author Pulikkal, Annie A.
Kolly, Anish
Prasanna Kumar, K. M.
Shivaprasad, C.
author_facet Pulikkal, Annie A.
Kolly, Anish
Prasanna Kumar, K. M.
Shivaprasad, C.
author_sort Pulikkal, Annie A.
collection PubMed
description CONTEXT: Celiac disease (CD) is a commonly encountered autoimmune condition in patients with type 1 diabetes (T1D). There is sparse data on the seroprevalence of immunoglobulin A (IgA) transglutaminase (tTG) in T1D patients of South Indian origin. AIMS: To detect the prevalence of IgA tTG in T1D patients of South Indian origin. To evaluate the relation between the presence of autoimmunity and metabolic control and complications of diabetes. MATERIALS AND METHODS: We conducted a cross-sectional study on 258 T1D patients. All the patients were subjected to biochemical tests and evaluated for microvascular complications. IgA tTG was estimated by ELISA. IgA tTG levels >40 AU/ml was considered positive. RESULTS: Of the 258 participants, 12 (4.65%) were found to be positive for IgA tTG antibodies. Distribution of IgA positivity was equal in both sexes. There was a significant negative correlation of IgA tTG positivity with hemoglobin and glycated hemoglobin (HbA1c). CONCLUSIONS: The seropositivity of CD in South Indian patients with T1D has been observed to be 4.68%. This is much lower compared to studies from North India. This can be explained by both the genetic and dietary factors. The seropositivity correlated negatively with hemoglobin and HbA1c.
format Online
Article
Text
id pubmed-4792026
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-47920262016-04-01 The seroprevalence of immunoglobulin A transglutaminase in type 1 diabetic patients of South Indian origin Pulikkal, Annie A. Kolly, Anish Prasanna Kumar, K. M. Shivaprasad, C. Indian J Endocrinol Metab Original Article CONTEXT: Celiac disease (CD) is a commonly encountered autoimmune condition in patients with type 1 diabetes (T1D). There is sparse data on the seroprevalence of immunoglobulin A (IgA) transglutaminase (tTG) in T1D patients of South Indian origin. AIMS: To detect the prevalence of IgA tTG in T1D patients of South Indian origin. To evaluate the relation between the presence of autoimmunity and metabolic control and complications of diabetes. MATERIALS AND METHODS: We conducted a cross-sectional study on 258 T1D patients. All the patients were subjected to biochemical tests and evaluated for microvascular complications. IgA tTG was estimated by ELISA. IgA tTG levels >40 AU/ml was considered positive. RESULTS: Of the 258 participants, 12 (4.65%) were found to be positive for IgA tTG antibodies. Distribution of IgA positivity was equal in both sexes. There was a significant negative correlation of IgA tTG positivity with hemoglobin and glycated hemoglobin (HbA1c). CONCLUSIONS: The seropositivity of CD in South Indian patients with T1D has been observed to be 4.68%. This is much lower compared to studies from North India. This can be explained by both the genetic and dietary factors. The seropositivity correlated negatively with hemoglobin and HbA1c. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4792026/ /pubmed/27042421 http://dx.doi.org/10.4103/2230-8210.176359 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Pulikkal, Annie A.
Kolly, Anish
Prasanna Kumar, K. M.
Shivaprasad, C.
The seroprevalence of immunoglobulin A transglutaminase in type 1 diabetic patients of South Indian origin
title The seroprevalence of immunoglobulin A transglutaminase in type 1 diabetic patients of South Indian origin
title_full The seroprevalence of immunoglobulin A transglutaminase in type 1 diabetic patients of South Indian origin
title_fullStr The seroprevalence of immunoglobulin A transglutaminase in type 1 diabetic patients of South Indian origin
title_full_unstemmed The seroprevalence of immunoglobulin A transglutaminase in type 1 diabetic patients of South Indian origin
title_short The seroprevalence of immunoglobulin A transglutaminase in type 1 diabetic patients of South Indian origin
title_sort seroprevalence of immunoglobulin a transglutaminase in type 1 diabetic patients of south indian origin
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792026/
https://www.ncbi.nlm.nih.gov/pubmed/27042421
http://dx.doi.org/10.4103/2230-8210.176359
work_keys_str_mv AT pulikkalanniea theseroprevalenceofimmunoglobulinatransglutaminaseintype1diabeticpatientsofsouthindianorigin
AT kollyanish theseroprevalenceofimmunoglobulinatransglutaminaseintype1diabeticpatientsofsouthindianorigin
AT prasannakumarkm theseroprevalenceofimmunoglobulinatransglutaminaseintype1diabeticpatientsofsouthindianorigin
AT shivaprasadc theseroprevalenceofimmunoglobulinatransglutaminaseintype1diabeticpatientsofsouthindianorigin
AT pulikkalanniea seroprevalenceofimmunoglobulinatransglutaminaseintype1diabeticpatientsofsouthindianorigin
AT kollyanish seroprevalenceofimmunoglobulinatransglutaminaseintype1diabeticpatientsofsouthindianorigin
AT prasannakumarkm seroprevalenceofimmunoglobulinatransglutaminaseintype1diabeticpatientsofsouthindianorigin
AT shivaprasadc seroprevalenceofimmunoglobulinatransglutaminaseintype1diabeticpatientsofsouthindianorigin